elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26750021-2E683D01-0477-4CF7-A76E-2F9AA6F739C7
Q26750021-2E683D01-0477-4CF7-A76E-2F9AA6F739C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750021-2E683D01-0477-4CF7-A76E-2F9AA6F739C7
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist
P2860
Q26750021-2E683D01-0477-4CF7-A76E-2F9AA6F739C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750021-2E683D01-0477-4CF7-A76E-2F9AA6F739C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f8b226b7ca7f12873c160e90df88e4df3470ad2e
P2860
Alzheimer disease pharmacologic treatment and treatment research.